New oral drug shows promise for male pattern baldness in 6 months
A new pill developed by Veradermix has delivered promising results in treating male pattern baldness, according to recent clinical trials.
Key Takeaways
AIVeradermix has developed a new drug that has shown promising results in treating male pattern hair loss, commonly known as male pattern baldness.
The company announced on Monday that its oral pill, designed to boost hair growth, proved successful in an advanced study. This news sent its shares up 7.5 percent to $117 in pre-market trading, according to Reuters.
The study met all its primary and secondary goals, demonstrating consistent benefits and strong hair growth, with generally good tolerance and no serious side effects linked to the treatment. The pill outperformed placebo in promoting hair growth after six months.